Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000035

Sr. VP & Chief Medical Officer sold 4,155 shares at an average $95.32 ($396,036)

  • Sr. VP & Chief Medical Officer acquired 2,955 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Adda Nathalie · Sr. VP & Chief Medical Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-09-20 Exercise or conversion : show line 1 in the form +2,955 $43.46 $128,424 4,155 D
2018-09-20 Sale : show line 2 in the form −500 $93.02 $46,509 3,655 D
2018-09-20 Sale : show line 3 in the form −453 $93.90 $42,535 3,202 D
2018-09-20 Sale : show line 4 in the form −1,229 $94.75 $116,451 1,973 D
2018-09-20 Sale : show line 5 in the form −602 $95.84 $57,699 1,371 D
2018-09-20 Sale : show line 6 in the form −1,371 $96.89 $132,842 0 D
Open-market sales · 4,155 sh · avg $95.32 · $396,036

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-09-20 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −2,955 $43.46 2025-06-29 2,955 72,270 D
Loading xslF345X03/edgar.xml…